Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Volkers

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Analytical Biochemistry|April 25, 2013
Factor XIIIa generation assay: a tool for studying factor XIII function in plasmaJohannes Dodt, Peter Volkers, Rainer Seitz
Statistics in Medicine|April 28, 2006
An introductory note to CHMP guidelines: choice of the non-inferiority margin and data monitoring committeesDavid Brown, Peter Volkers, Simon Day
British Journal of Haematology|October 31, 2015
Free factor XIII activation peptide (fAP-FXIII) is a regulator of factor XIII activity via factor XIII-BJohannes Dodt, Ralf Pasternack, Rainer Seitz, et al.
ALTEX|May 24, 2003
Suitability of temperature-sensitive transponders to measure body temperature during animal experiments required for regulatory testsJoachim Hartinger, Daniela Külbs, Peter Volkers, et al.
Age and Ageing|April 9, 2002
Prospective randomized double-blind study of the wound-debriding effects of collagenase and fibrinolysin/deoxyribonuclease in pressure ulcersRupert Püllen, Rüdiger Popp, Peter Volkers, et al.
Transfusion|November 2, 2006
Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infectionC Micha Nübling, Michael Chudy, Peter Volkers, et al.
ALTEX|April 2, 2004
Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation testUte Rosskopf-Streicher, Peter Volkers, Kerstin Noeske, et al.
ALTEX|June 15, 2005
[Serological test methods as replacement for infection trials in piglets to test the potency of E. coli vaccines for sows (dams)]Marion Krug, Dorothea Hausleitner, Regine Taddey, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|November 12, 2015
Evaluation of Risk Minimisation Measures for Blood Components - Based on Reporting Rates of Transfusion-Transmitted Reactions (1997-2013)Markus B Funk, Margarethe Heiden, Peter Volkers, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|November 16, 2010
Evaluation of Quality Parameters for Cord Blood DonationsUrsula Salge-Bartels, Helga Marie Huber, Kornelia Kleiner, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Analytical Biochemistry|April 25, 2013
Factor XIIIa generation assay: a tool for studying factor XIII function in plasmaJohannes Dodt, Peter Volkers, Rainer Seitz
Statistics in Medicine|April 28, 2006
An introductory note to CHMP guidelines: choice of the non-inferiority margin and data monitoring committeesDavid Brown, Peter Volkers, Simon Day
British Journal of Haematology|October 31, 2015
Free factor XIII activation peptide (fAP-FXIII) is a regulator of factor XIII activity via factor XIII-BJohannes Dodt, Ralf Pasternack, Rainer Seitz, et al.
ALTEX|May 24, 2003
Suitability of temperature-sensitive transponders to measure body temperature during animal experiments required for regulatory testsJoachim Hartinger, Daniela Külbs, Peter Volkers, et al.
Age and Ageing|April 9, 2002
Prospective randomized double-blind study of the wound-debriding effects of collagenase and fibrinolysin/deoxyribonuclease in pressure ulcersRupert Püllen, Rüdiger Popp, Peter Volkers, et al.
Transfusion|November 2, 2006
Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infectionC Micha Nübling, Michael Chudy, Peter Volkers, et al.
ALTEX|April 2, 2004
Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation testUte Rosskopf-Streicher, Peter Volkers, Kerstin Noeske, et al.
ALTEX|June 15, 2005
[Serological test methods as replacement for infection trials in piglets to test the potency of E. coli vaccines for sows (dams)]Marion Krug, Dorothea Hausleitner, Regine Taddey, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|November 12, 2015
Evaluation of Risk Minimisation Measures for Blood Components - Based on Reporting Rates of Transfusion-Transmitted Reactions (1997-2013)Markus B Funk, Margarethe Heiden, Peter Volkers, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|November 16, 2010
Evaluation of Quality Parameters for Cord Blood DonationsUrsula Salge-Bartels, Helga Marie Huber, Kornelia Kleiner, et al.
Pageof 2